Risk of cancer in individuals with Lynch-like syndrome and their families: a systematic review
- PMID: 36251064
- PMCID: PMC9889410
- DOI: 10.1007/s00432-022-04397-0
Risk of cancer in individuals with Lynch-like syndrome and their families: a systematic review
Abstract
Background: Lynch-like syndrome (LLS) tumors have similar clinicopathological features to Lynch syndrome (LS) tumors but have no identifiable pathogenic germline mismatch repair gene variant. However, cancer risks in LLS patients and first-degree relatives (FDRs) are not well defined.
Methods: To clarify LLS-associated cancer risks, a systematic review of all studies examining all cancer risks in LLS was performed. Searching of Medline, Embase, Pubmed, Cochrane and CINAHL databases and reference/citation checking identified relevant studies published between January 1, 1980 and February 11, 2021. Joanna Briggs Institute Appraisal Tools assessed the risk of bias.
Results: Six studies (five cohort/one cross-sectional) were eligible for study inclusion. One study found no difference in colorectal cancer (CRC) incidence between LLS and LS patients or CRC risks at aged 70 years. Three studies found CRC incidence in LLS FDRs was higher than the general population but lower than LS FDRs. Two studies showed no difference in CRC diagnosis age between LLS patients and LS patients. Endometrial cancer risks in LLS patients were higher than the general population but lower than LS patients.
Conclusion: Evidence of elevated CRC risks in LLS patients and FDRs supports increased colonoscopy surveillance strategies for LLS patients and FDRs in line with current recommendations for LS. Due to heterogeneity amongst LLS populations, extended intervals between screening may be advised for low-risk families. Studies to resolve the molecular characterization and definition of LLS are needed to clarify cancer risks associated with LLS which in turn may individualize surveillance strategies for LLS patients and families.
Keywords: Colorectal cancer; Extra-colonic cancer; Lynch syndrome; Lynch-like syndrome; Standard incidence ratio.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
The authors declare no conflict of interest.
Figures
Similar articles
-
Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study.BMC Cancer. 2020 May 24;20(1):460. doi: 10.1186/s12885-020-06926-x. BMC Cancer. 2020. PMID: 32448342 Free PMC article.
-
Clinicopathological characteristics of Lynch-like syndrome.Int J Clin Oncol. 2024 Jul;29(7):944-952. doi: 10.1007/s10147-024-02527-x. Epub 2024 Apr 20. Int J Clin Oncol. 2024. PMID: 38642190
-
Risk of cancer in cases of suspected lynch syndrome without germline mutation.Gastroenterology. 2013 May;144(5):926-932.e1; quiz e13-4. doi: 10.1053/j.gastro.2013.01.044. Epub 2013 Jan 24. Gastroenterology. 2013. PMID: 23354017
-
Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.Health Technol Assess. 2017 Sep;21(51):1-238. doi: 10.3310/hta21510. Health Technol Assess. 2017. PMID: 28895526 Free PMC article. Review.
-
Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: Systematic review and meta-analysis.Genet Med. 2022 May;24(5):971-985. doi: 10.1016/j.gim.2022.01.014. Epub 2022 Feb 15. Genet Med. 2022. PMID: 35177335 Review.
Cited by
-
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome.J Transl Med. 2023 Apr 26;21(1):282. doi: 10.1186/s12967-023-04143-1. J Transl Med. 2023. PMID: 37101184 Free PMC article.
-
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome.medRxiv [Preprint]. 2023 Mar 1:2023.02.27.23285541. doi: 10.1101/2023.02.27.23285541. medRxiv. 2023. Update in: J Transl Med. 2023 Apr 26;21(1):282. doi: 10.1186/s12967-023-04143-1. PMID: 36909643 Free PMC article. Updated. Preprint.
-
Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target Therapy.Cancers (Basel). 2024 May 27;16(11):2027. doi: 10.3390/cancers16112027. Cancers (Basel). 2024. PMID: 38893147 Free PMC article. Review.
-
Lynch-like syndrome with germline WRN mutation in Bulgarian patient with synchronous endometrial and ovarian cancer.Hered Cancer Clin Pract. 2023 Jul 14;21(1):13. doi: 10.1186/s13053-023-00257-1. Hered Cancer Clin Pract. 2023. PMID: 37452354 Free PMC article.
-
Tumor analysis of MMR genes in Lynch-like syndrome: Challenges associated with results interpretation.Cancer Med. 2024 Apr;13(7):e7041. doi: 10.1002/cam4.7041. Cancer Med. 2024. PMID: 38558366 Free PMC article.
References
-
- Bucksch K, Zachariae S, Aretz S, Buttner R, Holinski-Feder E, Holzapfel S, Huneburg R, Kloor M, von Knebel Doeberitz M, Morak M, Moslein G, Nattermann J, Perne C, Rahner N, Schmiegel W, Schulmann K, Steinke-Lange V, Strassburg CP, Vangala DB, Weitz J, Loeffler M, Engel C, German Consortium for Familial Intestinal, C Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study. BMC Cancer. 2020;20(1):460. doi: 10.1186/s12885-020-06926-x. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical